Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-25 @ 3:38 AM
NCT ID:
NCT00661102
Eligibility Criteria:
Inclusion Criteria:
* adult patients, \>=18 years of age;
* breast cancer or colorectal cancer patients;
* treated with oral Xeloda for \<=5 days;
* lack of hand-foot syndrome (palmar-plantar erythrodysesthesia).
Exclusion Criteria:
* existence of clinical symptoms suggesting hand-foot syndrome;
* use of doxorubicin, 5-FU and/or cytarabine for last 3 months;
* diabetes mellitus.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00661102
Study Brief:
Protocol Section:
NCT00661102